Laura Smeaton

4.7k total citations
75 papers, 2.8k citations indexed

About

Laura Smeaton is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Laura Smeaton has authored 75 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Infectious Diseases, 42 papers in Virology and 17 papers in Emergency Medicine. Recurrent topics in Laura Smeaton's work include HIV/AIDS Research and Interventions (45 papers), HIV Research and Treatment (42 papers) and HIV/AIDS drug development and treatment (37 papers). Laura Smeaton is often cited by papers focused on HIV/AIDS Research and Interventions (45 papers), HIV Research and Treatment (42 papers) and HIV/AIDS drug development and treatment (37 papers). Laura Smeaton collaborates with scholars based in United States, India and Botswana. Laura Smeaton's co-authors include Shahin Lockman, Richard T. D’Aquila, Max Essex, Roger Shapiro, Gregory K. Robbins, Robert W. Shafer, Victor De Gruttola, Ibou Thior, Martin Hirsch and Lisa Stevens and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Laura Smeaton

73 papers receiving 2.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Laura Smeaton	2.1k	1.5k	722	636	277	75	2.8k
Karam Mounzer	1.4k 0.6×	1.4k 0.9×	974 1.3×	471 0.7×	416 1.5×	117	3.0k
Ferdinand W.N.M. Wit	2.2k 1.0×	1.8k 1.2×	1.0k 1.4×	1.5k 2.4×	362 1.3×	109	3.6k
Sharon A. Riddler	2.9k 1.4×	2.6k 1.7×	751 1.0×	1.8k 2.8×	106 0.4×	95	4.4k
Catherine Godfrey	1.8k 0.8×	1.3k 0.8×	752 1.0×	651 1.0×	90 0.3×	80	2.8k
Maria Jesús Pérez‐Elías	2.4k 1.1×	1.7k 1.1×	1.1k 1.5×	786 1.2×	499 1.8×	179	3.4k
Princy Kumar	2.7k 1.3×	1.7k 1.1×	1.4k 1.9×	751 1.2×	120 0.4×	127	3.8k
François Dabis	2.4k 1.1×	1.4k 0.9×	1.4k 2.0×	969 1.5×	492 1.8×	67	3.3k
Anders Blaxhult	1.6k 0.7×	1.0k 0.7×	959 1.3×	498 0.8×	249 0.9×	73	2.2k
Clotilde Allavena	1.2k 0.6×	850 0.6×	601 0.8×	474 0.7×	129 0.5×	112	1.9k
Lawrence Deyton	2.2k 1.0×	1.9k 1.2×	762 1.1×	453 0.7×	236 0.9×	36	3.5k

Countries citing papers authored by Laura Smeaton

Since Specialization

Citations

This map shows the geographic impact of Laura Smeaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Smeaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Smeaton more than expected).

Fields of papers citing papers by Laura Smeaton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Smeaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Smeaton. The network helps show where Laura Smeaton may publish in the future.

Co-authorship network of co-authors of Laura Smeaton

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Smeaton. A scholar is included among the top collaborators of Laura Smeaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Smeaton. Laura Smeaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Torres, Thiago S., Laura Smeaton, Dimas Alexandre Kliemann, et al.. (2025). Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of Life. Quality of Life Research. 34(6). 1683–1694.

Scarsi, Kimberly K., Laura Smeaton, Anthony T. Podany, et al.. (2023). Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens. Contraception. 121. 109951–109951. 6 indexed citations

Smeaton, Laura, Debika Bhattacharya, Benjamin P. Linas, et al.. (2023). Perspectives on Adherence From the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach With 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment. Clinical Infectious Diseases. 76(11). 1959–1968. 5 indexed citations

Powis, Kathleen M., Shahin Lockman, Gbolahan Ajibola, et al.. (2022). Prolonged Cotrimoxazole Prophylaxis Has No Impact on Child Growth in the First Two Years of Life: Findings from a Randomized Controlled Trial in Botswana. The Journal of Pediatrics. 246. 266–270.e2. 2 indexed citations

Castillo‐Mancilla, José, Christina L. Aquilante, Michael F. Wempe, et al.. (2016). Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342). Journal of Antimicrobial Chemotherapy. 71(6). 1609–1618. 11 indexed citations

Powis, Kathleen M., Laura Smeaton, Michael D. Hughes, et al.. (2015). In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana. AIDS. 30(2). 211–220. 56 indexed citations

Powis, Kathleen M., Shahin Lockman, Laura Smeaton, et al.. (2014). Vitamin D Insufficiency in HIV-infected Pregnant Women Receiving Antiretroviral Therapy is Not Associated With Morbidity, Mortality or Growth Impairment in Their Uninfected Infants in Botswana. The Pediatric Infectious Disease Journal. 33(11). 1141–1147. 6 indexed citations

Russell, Elizabeth S., Terence Mohammed, Laura Smeaton, et al.. (2014). Immune Activation Markers in Peripartum Women in Botswana: Association with Feeding Strategy and Maternal Morbidity. PLoS ONE. 9(3). e89928–e89928. 4 indexed citations

Smeaton, Laura, Thomas Campbell, Cynthia Riviere, et al.. (2014). Renal and Metabolic Toxicities Following Initiation of HIV-1 Treatment Regimen in a Diverse, Multinational Setting: A Focused Safety Analysis of ACTG PEARLS (A5175). HIV Clinical Trials. 15(6). 246–260. 9 indexed citations

10.

Safren, Steven A., Katie B. Biello, Laura Smeaton, et al.. (2014). Psychosocial Predictors of Non-Adherence and Treatment Failure in a Large Scale Multi-National Trial of Antiretroviral Therapy for HIV: Data from the ACTG A5175/PEARLS Trial. PLoS ONE. 9(8). e104178–e104178. 46 indexed citations

11.

Safren, Steven A., Ellen Hendriksen, Laura Smeaton, et al.. (2011). Quality of Life Among Individuals with HIV Starting Antiretroviral Therapy in Diverse Resource-Limited Areas of the World. AIDS and Behavior. 16(2). 266–277. 38 indexed citations

12.

Firnhaber, Cynthia, Laura Smeaton, Timothy Flanigan, et al.. (2010). Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas. International Journal of Infectious Diseases. 14(12). e1088–e1092. 56 indexed citations

13.

Hulgan, Todd, John P. Donahue, Laura Smeaton, et al.. (2009). Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors. European Journal of Clinical Pharmacology. 65(11). 1081–1088. 3 indexed citations

14.

Blackard, Jason T., Yoichi Hiasa, Laura Smeaton, et al.. (2007). Compartmentalization of Hepatitis C Virus (HCV) during HCV/HIV Coinfection. The Journal of Infectious Diseases. 195(12). 1765–1773. 43 indexed citations

15.

Jacobson, Francine L., Samson Munn, Darius Jazayeri, et al.. (2004). Diagnostic accuracy of chest X-rays acquired using a digital camera for low-cost teleradiology. International Journal of Medical Informatics. 73(1). 65–73. 43 indexed citations

16.

Shafer, Robert W., Laura Smeaton, Gregory K. Robbins, et al.. (2003). Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection. New England Journal of Medicine. 349(24). 2304–2315. 186 indexed citations

17.

Pollard, Richard B., Camlin Tierney, Diane V. Havlir, et al.. (2002). A Phase II Randomized Study of the Virologic and Immunologic Effect of Zidovudine + Stavudine versus Stavudine Alone and Zidovudine + Lamivudine in Patients with >300 CD4 Cells Who Were Antiretroviral Naive (ACTG 298). AIDS Research and Human Retroviruses. 18(10). 699–704. 7 indexed citations

18.

Smeaton, Laura, John G. Gerber, Edward P. Acosta, et al.. (2002). The Pharmacokinetics of Amprenavir, Zidovudine, and Lamivudine in the Genital Tracts of Men Infected with Human Immunodeficiency Virus Type 1 (AIDS Clinical Trials Group Study 850). The Journal of Infectious Diseases. 186(2). 198–204. 34 indexed citations

19.

Marschner, Ian C., Ann C. Collier, Robert W. Coombs, et al.. (1998). Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy. The Journal of Infectious Diseases. 177(1). 40–47. 182 indexed citations

20.

Welles, Seth L., J. Brooks Jackson, Belinda Yen‐Lieberman, et al.. (1996). Prognostic Value of Plasma Human Immunodeficiency Virus Type 1 (HIV-l) RNA Levels in Patients with Advanced HIV-l Disease and with Little or No Prior Zidovudine Therapy. The Journal of Infectious Diseases. 174(4). 696–703. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact